1. Glcci1 deficiency leads to proteinuria.
- Author
-
Nishibori Y, Katayama K, Parikka M, Oddsson A, Nukui M, Hultenby K, Wernerson A, He B, Ebarasi L, Raschperger E, Norlin J, Uhlén M, Patrakka J, Betsholtz C, and Tryggvason K
- Subjects
- Animals, Cytoplasm metabolism, Dexamethasone pharmacology, Disease Models, Animal, Gene Expression Regulation, Developmental drug effects, Gene Expression Regulation, Developmental physiology, Glucocorticoids pharmacology, Kidney Glomerulus abnormalities, Male, Mice, Mice, Inbred ICR, Oligonucleotides, Antisense pharmacology, Pronephros abnormalities, Proteinuria pathology, Rabbits, Receptors, Glucocorticoid genetics, Zebrafish, Zebrafish Proteins, Kidney Glomerulus physiopathology, Podocytes physiology, Pronephros physiopathology, Proteinuria metabolism, Proteinuria physiopathology, Receptors, Glucocorticoid deficiency
- Abstract
Unbiased transcriptome profiling and functional genomics approaches identified glucocorticoid-induced transcript 1 (GLCCI1) as being a transcript highly specific for the glomerulus, but its role in glomerular development and disease is unknown. Here, we report that mouse glomeruli express far greater amounts of Glcci1 protein compared with the rest of the kidney. RT-PCR and Western blotting demonstrated that mouse glomerular Glcci1 is approximately 60 kD and localizes to the cytoplasm of podocytes in mature glomeruli. In the fetal kidney, intense Glcci1 expression occurs at the capillary-loop stage of glomerular development. Using gene knockdown in zebrafish with morpholinos, morphants lacking Glcci1 function had collapsed glomeruli with foot-process effacement. Permeability studies of the glomerular filtration barrier in these zebrafish morphants demonstrated a disruption of the selective glomerular permeability filter. Taken together, these data suggest that Glcci1 promotes the normal development and maintenance of podocyte structure and function.
- Published
- 2011
- Full Text
- View/download PDF